148 related articles for article (PubMed ID: 16650165)
1. Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria.
Cassano N; Raho G; Filieri M; D'Argento V; Amoruso A; Filotico R; Vena GA
Int J Dermatol; 2006 Apr; 45(4):394-6. PubMed ID: 16650165
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
Augustin M; Ehrle S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
[TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
[TBL] [Abstract][Full Text] [Related]
5. [Desloratadine for chronic idiopathic urticaria].
Rottem M; Elbirt D; Sthoeger Z;
Harefuah; 2005 Aug; 144(8):547-53, 599, 598. PubMed ID: 16146151
[TBL] [Abstract][Full Text] [Related]
6. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity.
Kiyici S; Gul OO; Baskan EB; Hacioglu S; Budak F; Erturk E; Imamoglu S
Clin Exp Dermatol; 2010 Aug; 35(6):603-7. PubMed ID: 19874329
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
[TBL] [Abstract][Full Text] [Related]
8. Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
Lachapelle JM; Decroix J; Henrijean A; Roquet-Gravy PP; De Swerdt A; Boonen H; Lecuyer M; Suys E; Speelman G; Vastesaeger N
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):288-92. PubMed ID: 16503889
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
Ortonne JP; Grob JJ; Auquier P; Dreyfus I
Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
[TBL] [Abstract][Full Text] [Related]
11. CRP relevance in clinical assessment of chronic spontaneous urticaria Tunisian patients.
Maouia A; Youssef M; Leban N; Ben Chibani J; Helal AN; Kassab A
Cutan Ocul Toxicol; 2017 Dec; 36(4):387-392. PubMed ID: 28351163
[TBL] [Abstract][Full Text] [Related]
12. Influence of desloratadine on selected oxidative stress markers in patients between 3 and 10 years of age with allergic perennial rhinitis.
Sadowska-Woda I; Bieszczad-Bedrejczuk E; Rachel M
Eur J Pharmacol; 2010 Aug; 640(1-3):197-201. PubMed ID: 20493834
[TBL] [Abstract][Full Text] [Related]
13. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria.
Khalaf AT; Liu XM; Sheng WX; Tan JQ; Abdalla AN
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):487-92. PubMed ID: 18081747
[TBL] [Abstract][Full Text] [Related]
15. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
Allergy; 2009 Apr; 64(4):605-12. PubMed ID: 19133920
[TBL] [Abstract][Full Text] [Related]
16. Desloratadine: a nonsedating antihistamine.
Limon L; Kockler DR
Ann Pharmacother; 2003 Feb; 37(2):237-46; quiz 313-6. PubMed ID: 12549956
[TBL] [Abstract][Full Text] [Related]
17. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Ring J; Hein R; Gauger A; Bronsky E; Miller B
Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962
[TBL] [Abstract][Full Text] [Related]
18. Markers of antioxidant defence system and lipid peroxidation in peripheral blood of female patients with chronic idiopathic urticaria.
Kasperska-Zajac A; Brzoza Z; Polaniak R; Rogala B; Birkner E
Arch Dermatol Res; 2007 Mar; 298(10):499-503. PubMed ID: 17171548
[TBL] [Abstract][Full Text] [Related]
19. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
[TBL] [Abstract][Full Text] [Related]
20. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Soccio AL; Ferrannini A; Vacca A
Br J Dermatol; 2006 Dec; 155(6):1279-82. PubMed ID: 17107402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
